Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity
Stock Information for Palatin Technologies Inc.
Loading
Please wait while we load your information from QuoteMedia.